![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
METHOD DEVELOPMENT AND VALIDATION OF IRBESARTAN AND HYDROCHLORTHIAZIDE BY RP-HPLC IN BULK AND PHARMACEUTICAL DOSAGE FORM
P. Sathya Narayana*, R. Ananth Kumar, D. Balaji, J. China Babum and T. Anil Krishna
ABSTRACT A simple, precise, accurate and rapid reverse phase high performance liquid chromatographic method had been developed for simultaneous estimation of Irbesartan (IRBE) and Hydrochlorothiazide (HCTZ) in bulk and Pharmaceutical dosage form. A Phenomex Luna C-18 column having I’d of 150×4.6 mm and 5μm particle size was used. The method was carried out in gradient program using mobile phase, 0.02M Potassium dehydrogenate orthophosphate: acetonitrile (60:40 v/v) adjusted to pH-3.4 using dilute ortho phosphoric acid. Flow rate was adjusted to 1.0ml/min and effluents were monitored at 224nm. The retention time obtained for Irbesartan and HCTZ was 2.59 & 8.13min respectively. The calibration curves were linear in the concentration range of 100-300μg/ml for Irbesartan and 50-150μg/ml for HCTZ. The developed method was validated in accordance to ICH guidelines. Keywords: Irbesartan, Hydrochlorothiazide, Acetonitrile, Buffer, RP-HPLC. [Download Article] [Download Certifiate] |